YTHDC2 and metabolic dysfunction-associated steatotic liver disease: As a result, they concluded that downregulation of YTHDC2 results in overexpression of lipogenic genes and accumulation of excessive triglycerides (TGs) in the liver in an m6A-dependent manner, which facilitates the advancement of NAFLD.